Topics
- Avoid complacency from past "good" FDA / ISO audits
- The Globalization of the Supply Chain and What That Means
- Essential Supplier Controls
- Supplier Ranking Models
- The Tiered Risk-Based Audit Approach
- Where to direct scarce resources
- Maintain "the edge"; proactively address "entropy"
Who should Attend
Attendees from Diagnostic, Medical Device, Neutraceutical and Biologics and Pharmaceutical fields Regulatory Affairs, Senior management, Purchasing, Quality Assurance, Engineering, Production, All personnel involved in a U.S. FDA-regulated environment.
